Current Oncology

MDPI AG

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Current Oncology is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,200 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
1198-0052 · 1718-7729
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
2,200 CHF
Articles in DOAJ
3815
Declared review time
6 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-08-27
  • MEDLINE · 2018-01-01
  • PUBMED · 2020-11-28
Indexing
DOAJ · MEDLINE · PUBMED
APC
2,200 CHF
Declared review time (DOAJ)
6 weeks
Actual review time (measured)
45 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

3815

Most recent article

last month

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

5671

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

96

i10-index

2102

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-10
Added to DOAJ
2021-08-27
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2025
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
93%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9502503
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer survivorship and care
  • Cancer survivorship and care
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
Show all subjects (50)
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Sarcoma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Glioma Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Ovarian cancer diagnosis and treatment
  • BRCA gene mutations in cancer
  • Colorectal Cancer Screening and Detection
  • Ovarian cancer diagnosis and treatment
  • Colorectal Cancer Screening and Detection

Keywords (DOAJ)

  • radiation oncology
  • oncologic pathology
  • oncology education
  • cancer control and prevention
  • clinical oncology practice guidelines
  • integrative oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: